Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Kuala Lumpur-based Supagene.Asia operates in Biotechnology Research. Ownership is privately held; it publishes at supagene.asia. It holds one address on record, all in Malaysia. The record counts 8 people. Its latest round on record is Non equity assistance, US$24.1K. It is listed alongside ten similar brands, mostly in Biotechnology Research.
Our vision is to provide every individual with the possibility to conduct genetic testing that enables them to discover new insights about their health. Our current mission is to make a meaningful impact on people’s lives benefiting from genetic science through preventive and personalized wellness.
| Countries | 1 |
|---|---|
| Primary country | MY |
All codes: MY
| Rounds | 1 |
|---|---|
| Axis | 2019 to 2026 |
| Non equity assistance · 9 Oct 2021 | US$ 24.1K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 8 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Malaysia only. Primary: Kuala Lumpur, Kuala Lumpur 50470.
One round. Latest 9 October 2021: non equity assistance, US$24,100, investor Cyberview Living Lab Accelerator.
8 profiles list Supagene.Asia as a peer — 76th percentile in Biotechnology Research. It lists ten peers of its own. Prima Nexus and Neo Nexon list it back.